Nadroparin calcium

DRUG4 trials

Sponsors

Academisch Ziekenhuis Leiden, Italfarmaco, Medical University of Vienna, Shanghai Zhongshan Hospital

Conditions

Advanced CancerEsophageal NeoplasmsLung NeoplasmsMetastatic CancerPregnancy and ThrombophiliaVenous ThromboembolismVenous thromboembolism

Phase 3

Prevention of Venous and Arterial Thromboembolism, in Cancer Patients Undergoing Chemotherapy, With a Low Molecular Weight Heparin (Nadroparin Calcium)

CompletedNCT00951574

ItalfarmacoAdvanced Cancer, Metastatic Cancer

Start: 2003-10-31End: 2008-07-31Updated: 2012-02-01

Heparin for Pregnant Women With Thrombophilia

Medical University of ViennaPregnancy and Thrombophilia

Start: 2010-01-31End: 2012-12-31Target: 300Updated: 2009-11-25

Phase 4

DISTINCT: inDividual, targeted thrombosIS prophylaxis versus the standard ‘one size fits all’ approach in patients undergoing Total hIp or total kNee replaCemenT: a national, multicenter, randomized, multi-arm, open-label trial

RecruitingCTIS2023-510186-98-00

Academisch Ziekenhuis LeidenVenous thromboembolism

Start: 2024-10-23Target: 10078Updated: 2025-11-14

Unknown Phase

The Impact of Different Anticoagulant Therapy on Hemorrhage and Coagulation After Thoracic Surgery

CompletedNCT01267305

Shanghai Zhongshan HospitalEsophageal Neoplasms, Lung Neoplasms, Venous Thromboembolism

Start: 2011-01-31End: 2013-08-31Updated: 2014-04-29

Related Papers

Low molecular weight heparin once versus twice for thromboprophylaxis following esophagectomy: a randomised, double-blind and placebo-controlled trial.

2015-07-0123 citations